At week 48 , 271 ( 93 % ) of 290 participants in the switch group and 126 ( 88 % ) of 143 participants in the no-switch group maintained plasma viral loads below 50 copies per mL ( difference 53 % , 95 % CI -05 to 120 ; p = 0066 ) .